Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics
eLife · 2025
DOI: 10.7554/elife.100570 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Rui Vasco Simoes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical MRI, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Glucose, Deuterium, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions, Fundação para a Ciência e a Tecnologia, Fundação Champalimaud.
Abstract (Originalsprache)
Glioblastomas are aggressive brain tumors with dismal prognosis. One of the main bottlenecks for developing more effective therapies for glioblastoma stems from their histologic and molecular heterogeneity, leading to distinct tumor microenvironments and disease phenotypes. Effectively characterizing these features would improve the clinical management of glioblastoma. Glucose flux rates through glycolysis and mitochondrial oxidation have been recently shown to quantitatively depict glioblastoma proliferation in mouse models (GL261 and CT2A tumors) using dynamic glucose-enhanced (DGE) deuterium spectroscopy. However, the spatial features of tumor microenvironment phenotypes remain hitherto unresolved. Here, we develop a DGE Deuterium Metabolic Imaging (DMI) approach for profiling tumor microenvironments through glucose conversion kinetics. Using a multimodal combination of tumor mouse models, novel strategies for spectroscopic imaging and noise attenuation, and histopathological correlations, we show that tumor lactate turnover mirrors phenotype differences between GL261 and CT2A mouse glioblastoma, whereas recycling of the peritumoral glutamate-glutamine pool is a potential marker of invasion capacity in pooled cohorts, linked to secondary brain lesions. These findings were validated by histopathological characterization of each tumor, including cell density and proliferation, peritumoral invasion and distant migration, and immune cell infiltration. Our study bodes well for precision neuro-oncology, highlighting the importance of mapping glucose flux rates to better understand the metabolic heterogeneity of glioblastoma and its links to disease phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical MRI, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
- Neuroengineering and Computational Neuroscience, Institute for Research and Innovation in Health (i3S), Porto, Portugal.
- Center of Functionally Integrative Neuroscience (CFIN) and MINDLab, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Physics and Astronomy, Aarhus University, Aarhus, Denmark.
- Histopathology Platform, Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
ORCID-Profile: Rui Vasco Simoes, Noam Shemesh
Förderung
- H2020 Marie Skłodowska-Curie Actions
- Fundação para a Ciência e a Tecnologia
- Fundação Champalimaud
Zitieren
APA
Simoes, R. V., Henriques, R. N., Olesen, J. L., Cardoso, B. M., Fernandes, F. F., Monteiro, M. A. V., Jespersen, S. N., Carvalho, T., & Shemesh, N. (2025). Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics. eLife. https://doi.org/10.7554/elife.100570
Vancouver
Simoes RV, Henriques RN, Olesen JL, Cardoso BM, Fernandes FF, Monteiro MAV, et al. Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics. eLife. 2025. doi:10.7554/elife.100570
BibTeX
@article{Simoes2025,
author = {Simoes, Rui Vasco and Henriques, Rafael Neto and Olesen, Jonas L and Cardoso, Beatriz M and Fernandes, Francisca F and Monteiro, Mariana A V and Jespersen, Sune N and Carvalho, Tânia and Shemesh, Noam},
title = {Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100570}
}
EUVIMED